Filing Details

Accession Number:
0001179110-12-003400
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-23 21:44:16
Reporting Period:
2012-02-22
Filing Date:
2012-02-23
Accepted Time:
2012-02-23 21:44:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
916085 Health Net Inc HNT Hospital & Medical Service Plans (6324) 954288333
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1435524 T. Patricia Clarey 21650 Oxnard Street
Woodland Hills CA 91367
Svp, Chief Regulatory Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-02-22 730 $38.86 47,858 No 4 F Direct
Common Stock Disposition 2012-02-22 500 $38.05 47,358 No 4 S Direct
Common Stock Disposition 2012-02-22 4,180 $38.68 43,178 No 4 S Direct
Common Stock Disposition 2012-02-23 208 $38.67 42,970 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares forfeited in lieu of payment of tax liability in connection with the vesting of 25% of a grant of 6,250 restricted stock units made to the Reporting Person on February 22, 2010 pursuant to the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2010 Grant").
  2. The number of shares forfeited by the Reporting Person was based on the closing price of the Issuer's common stock on February 22, 2012, the vesting date of the 2010 Grant.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.47 to $38.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person on February 22, 2012, as reported on this Form 4, were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.51 to $38.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person on February 22, 2012, as reported on this Form 4, were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.31 to $39.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person on February 23, 2012, as reported on this Form 4, were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  6. Includes shares held by the Patricia T. Clarey Revocable Trust, of which the Reporting Person is sole trustee and beneficiary.